LONDON--(BUSINESS WIRE)--Aug 31, 2018-- analysts forecast the global cell culture consumables market to grow at a CAGR of around 10% during the forecast period, according to their latest market research report.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180831005451/en/

Technavio has published a new market research report on the global cell culture consumables market from 2018-2022. (Graphic: Business Wire)

The increasing demand for 3D cell culture is one of the major trends being witnessed in the . 3D cell culture has been developed to enhance the structure of the cells undergoing culture. The 3D cell culture is gaining importance in cell culture because it provides a suitable microenvironment for optimal cell growth, differentiation, function, and ability to create tissue-like structures in vitro.

This report is available at a USD 1,000 discount for a limited time only:

According to Technavio analysts, one of the key factors contributing to the growth of the global cell culture consumables market is the increase in infectious disease:

Global cell culture consumables market: Increase in infectious disease

The prevalence of infectious diseases is increasing at a fast rate due to the growing population. There have been several cases of viral infections such as Ebola, severe acute respiratory syndrome (SARS), swine flu, Zika, and Lassa fever, which are considered pandemic. These infections spread at a fast rate, generally less than a week.

According to a senior analyst at Technavio for research on life science research tools, “Since the past few decades, the egg-based manufacturing process for drugs was the most preferred method for developing influenza vaccines. However, with the recent technological advances in cell culture, many cell-based influenza vaccines are being made using animal cell lines. In November 2012, the FDA approved the Flucelvax vaccine, manufactured by the cell culture technology.”

Global cell culture consumables market: Segmentation analysis

The global cell culture consumables market research report provides market segmentation by the application (pharmaceutical and biotechnology, cancer research, and others (application in tissue engineering and regenerative medicine) and by region (the Americas, EMEA, and APAC). It provides an in-depth analysis of the prominent factors influencing the market, including drivers, opportunities, trends, and industry-specific challenges.

Of the two major applications, the pharmaceutical and biotechnology segment held the largest market share in 2017, contributing to over 38% of the market. However, the cancer research segment is expected to witness maximum incremental growth during the forecast period.

The Americas accounts for the largest share of the global cell culture consumables market. The market is driven by factors such as the increasing incidence of infectious diseases requiring antibiotics and other drugs and the significant use of the cell-based products to treat various chronic diseases such as cancer, tuberculosis, diabetes, and CVDs. Further, the presence of sophisticated infrastructure and growing R&D activities also drive the demand for the cell culture consumables in the region.

Looking for more information on this market?

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

Market ecosystem Market characteristics Market segmentation analysis

Market Sizing

Market definition Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

Regional comparison Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

Vendors covered Vendor classification Market positioning of vendors Competitive scenario

About Technavio

is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at .

View source version on businesswire.com:https://www.businesswire.com/news/home/20180831005451/en/

CONTACT: Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

www.technavio.com

KEYWORD:

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY RESEARCH SCIENCE

SOURCE: Technavio Research

Copyright Business Wire 2018.

PUB: 08/31/2018 03:17 PM/DISC: 08/31/2018 03:16 PM

http://www.businesswire.com/news/home/20180831005451/en